drugset / Trial / NCT01507376

Comparing the Efficacy of Urinary and Recombinant Human Chorionic Gonadotropin (hCG) on Oocyte Maturity

NCT01507376

Phase 3 Completed 180 enrolled Royan Institute
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is a prospective randomized clinical trial to compare the efficacy of the urinary and recombinant hCG on oocyte quality for ovulation induction in women undergoing IVF/ICSI.

Timeline

Start
2010-10
Primary completion
2012-09
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject human chorionic gonadotropin Protein / enzyme biologic 10000 iu
Subject recombinant HCG Protein / enzyme biologic 250 ug
Subject recombinant HCG Protein / enzyme biologic 500 ug

Indications

No indication recorded.